Kathleen Goetz is Director of TEKLA LIFE SCIENCES INVESTORS. Currently has a direct ownership of 1,085 shares of HQL, which is worth approximately $15,895. The most recent transaction as insider was on Apr 09, 2024, when has been sold 400 shares (Common Stock) at a price of $13.32 per share, resulting in proceeds of $5,328. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.09K
0% 3M change
58.39% 12M change
Total Value Held $15,895

Kathleen Goetz Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 09 2024
BUY
Open market or private purchase
$5,328 $13.32 p/Share
400 Added 26.94%
1,085 Common Stock
Mar 23 2022
BUY
Open market or private purchase
$1,497 $16.27 p/Share
92 Added 11.84%
685 Shares of beneficial i...
Jan 26 2022
BUY
Open market or private purchase
$10,401 $17.54 p/Share
593 Added 50.0%
593 Shares of beneficial i...

Also insider at

HQH
TEKLA HEALTHCARE INVESTORS Financial Services
THQ
Tekla Healthcare Opportunities Fund Financial Services
THW
Tekla World Healthcare Fund Financial Services
KG

Kathleen Goetz

Director
Boston, MA

Track Institutional and Insider Activities on HQL

Follow TEKLA LIFE SCIENCES INVESTORS and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HQL shares.

Notify only if

Insider Trading

Get notified when an Tekla Life Sciences Investors insider buys or sells HQL shares.

Notify only if

News

Receive news related to TEKLA LIFE SCIENCES INVESTORS

Track Activities on HQL